All In MedTech

FDA Clearance Tracker · P100010-S070

Arctic Front Advance Pro Cardiac Cryoablation Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 4, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 4, 2018

Approved

Time to decision

165 days

Received Nov 20, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100010-S070
Device name
Arctic Front Advance Pro Cardiac Cryoablation Catheter
Applicant location
Mounds View, MN
Received
Nov 20, 2017
Decided
May 4, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100010

Device type

Device class
Class III

Every decision under product code OAE

FDA's approval statement

As written in FDA's record.

Approval for two new models to be added to the Arctic Front family of Cardiac Cryoablation Catheters, AFAPRO23 and AFAPRO28.

Source documents

Other decisions for Medtronic Cryocath, LP

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.